Clostridium perfringens cell wall peptidoglycan (CP-PGN) (CP-PGN)

Clostridium perfringens cell wall peptidoglycan is a complex, mesh-like polymer that provides essential structural integrity and osmotic protection to this Gram-positive anaerobic bacterium (Vollmer et al., 2008). It is composed of alternating residues of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), cross-linked by short peptide bridges that are critical for maintaining the cell's rod-like shape and facilitating binary fission (Schleifer & Kandler, 1972). In clinical settings, C. perfringens is a highly virulent pathogen, serving as the primary causative agent of gas gangrene (clostridial myonecrosis) and various forms of food poisoning and enteritis (Stevens et al., 2012). Because the peptidoglycan biosynthetic pathway is unique to bacteria and absent in eukaryotic hosts, it represents a highly effective target for antimicrobial therapy (Kohanski et al., 2010). Antibiotics such as beta-lactams (e.g., Penicillin G) and glycopeptides (e.g., Vancomycin) disrupt the assembly or cross-linking of this layer, leading to cell wall instability and subsequent osmotic lysis of the pathogen (StatPearls, 2023). Understanding the specific modifications of C. perfringens peptidoglycan is also vital for addressing emerging antibiotic resistance and developing novel therapeutic strategies (PubMed, 2021).

Other names

MureinC. perfringens peptidoglycan layerBacterial sacculus

Inhibition of peptidoglycan cross-linking (transpeptidation) by binding to penicillin-binding proteins (PBPs) or by sequestering the D-Ala-D-Ala terminus of peptidoglycan precursors, thereby preventing cell wall assembly and causing osmotic lysis (Kohanski et al., 2010; StatPearls, 2023).